EU Annex 1 - Manufacture of Sterile Medicinal Products

Understanding the new draft

ONLINE

New draft released February 2020

The new version of Annex 1 has major updates, in bothstructure and content.
This session guides you through the changes, point by point.

Course description

This interactive training will be supported by many examples and group discussions around Sterile manufacturing issues. The new draft of EMA Annex 1 of Eudralex vol. 4 will be will be accurately reviewed and each new expectation will be deciphered and analyzed to be translated into operational terms .

Course outline

  • Scope and Principle: Reinforcement of the specific terminology CCS (Contamination Control Strategy)
  • Pharmaceutical Quality System (PQS) and requirement for an effective risk management system integrated into the product life cycle
  • Premises: Focus on Barrier Technologies Systems (Isolators and RABS) – Cleanroom and cleanair equipment qualification – Disinfection
  • Equipment
  • Utilities: Focus on Water Systems
  • Personnel: Focus on the Qualification of the personnel
  • Production and Specific Technologies: For this section, the speakers will be able to adapt their speaking to answer to the specific cases of all the participants.
  • Viable and non-viable environmental and process monitoring: Particular Focus on Aseptic Process Simulation
  • Quality control (QC)

The course will be illustrated from specific situations met by the speakers in Pharmaceutical companies.

Learning objectives

The main objective of this session is to have an exhaustive overview and comprehension of the new draft of the Annex 1 published on February 2020.

Who should attend

This training is intended for personnel categories such as Quality Assurance, Sterility Assurance, Production, Facilities, Engineering, Auditors, Qualified Persons and all support functions involved in contamination in sterile environments.

#5230

Share
Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email
Date & Time
November 30, 2020
- December 3, 2020
09.00-12.30 CET
IndustryPharmaceuticals
LanguageEnglish
LevelIntermediate
LocationOnline
RegionEU

2 050,00 1 850,00

No. persons
Discount:
3 persons or more 15% if registered and invoiced together for the same course.

make an inquiry

In-House Training

This course is available as an In-House Training course. Let us know if you wish to customize a course or if you are a large group with the same requirements.

We take great care of your contact details. To learn more, read our Privacy Policy

Your Instructor(s)

Leading specialist with long experience of training are guiding you through regulations, guidelines, interpretations, requirements and applications.

Emmanuel Gourvil

Pierre Devaux

Search

Cookies

For your best experience are we using cookies on this website.